All Industries

Top Biotech Companies

5,081 Biotech companies, sorted by total funding raised.

VerastemIPO

Biopharmaceutical company developing RAS/MAPK pathway therapies for cancer patients.

Boston, United States51–200Biopharmaceutical, Healthcare
Corporate Round·$392.5M·Nov 2025
SuperGenClosed

Pharmaceutical company dedicated to the discovery and development of novel cancer therapies.

Dublin, United States201–500Biotech
Corporate Round·$391.6M·Oct 2009
Believer MeatsClosed

Mission to make it possible for all future generations to eat meat

Chicago, United States51–200Biotech, cultured meat
Series B·$390.3M·Dec 2021
23andMeAcquired

Developing new ways to help people make sense of their genetic information

San Francisco Bay Area, United States501–1000Biotech, DNA Testing
Series B·$382.5M·Dec 2020
Jade BiosciencesAcquired

Jade Biosciences develops innovative biologics and disease-modifying therapies targeting autoimmu...

Waltham, United States11–50Biotech, Healthcare
Corporate Round·$380.0M·Apr 2025
AbSciIPO

Generative AI drug creation platform for designing and developing biologics

Vancouver, United States201–500Artificial Intelligence, Biotech
Growth Equity·$379.5M·Aug 2025
SaludaIPO

Neurostimulation company developing closed-loop spinal cord stimulation technology for chronic pa...

Macquarie Park, AustraliaBiotech, Healthcare
Growth Equity·$375.0M·Jan 2025
MapLight TherapeuticsIPO

AI-powered neuroscience drug discovery platform for CNS diseases.

San Francisco, United States51–200Artificial Intelligence, Biotech
Series D·$372.5M·Jul 2025
Formation Bio

Tech-native pharma company acquiring and developing clinical-stage assets via proprietary sourcin...

New York, United States51–200Artificial Intelligence, Biotech
Series D·$372.0M·Jun 2024
Definium Therapeutics, Inc. Common SharesIPO

Clinical-stage biopharmaceutical company (formerly MindMed) developing psychedelic-based psychiat...

New York, United States11–50Biotech, Healthcare
Corporate Round·$371.0M·Aug 2023
Tizona Therapeutics

Clinical-stage oncology company developing first-in-class cancer immunotherapy treatments targeti...

South San Francisco, United States11–50Biotech, Healthcare
Corporate Round·$370.0M·Jul 2020
Human Longevity

Biotech startup focused on innovative longevity and precision medicine technologies

San Diego, United States51–200Biotech
Series B·$369.8M·Aug 2024
Vividion TherapeuticsAcquired

Vividion Therapeutics is a Bayer-owned biopharmaceutical company using chemoproteomics-based drug...

San Diego, United States201–500Biotech, Drug Discovery
Series C·$368.0M·Feb 2021
TE
Thrive Earlier DetectionClosed

Liquid biopsy cancer screening company integrating multi-cancer early detection into routine medi...

Cambridge, United States51–200Biotech, Diagnostics
Series B·$367.0M·Jul 2020
Alentis Therapeutics

Clinical-stage biotech developing anti‑Claudin-1 ADCs and antibodies for cancer and organ fibrosis.

Basel, Switzerland51–200Biotech, Drug Discovery
Series D·$365.9M·Nov 2024
Windward Bio

Clinical-stage drug development company improving outcomes for people with advanced immunological...

Basel, United States1–10Biotech, Healthcare
Growth Equity·$365.0M·May 2026
DELFI Diagnostics

Develops blood-based liquid biopsy tests using fragmentomics and machine learning to detect and m...

Baltimore, United States51–200Artificial Intelligence, Biotech
Venture Round·$364.8M·Dec 2025
Oricell Therapeutics

Clinical-stage oncology company developing novel CAR-T cell therapies for hematological malignanc...

Shanghai, China51–200Oncology, Therapeutics
Venture Round·$364.0M·Apr 2026
Umoja

Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.

Seattle, United States201–500Biotech, Drug Discovery
Series C·$363.0M·Jan 2025
Ventus Therapeutics

Clinical-stage biopharmaceutical company using structural biology and computational chemistry to ...

Montreal, Canada11–50Biotech, Drug Discovery
Grant·$360.1M·Apr 2023
Nalu Med

Medical device company making FDA-cleared neurostimulation system for chronic nerve pain.

Carlsbad, United States51–200Biotech, Healthcare
Series F·$358.0M·Sep 2024
Terremoto Biosciences

Clinical-stage biotech company using covalent chemistry to develop small molecule medicines for o...

South San Francisco, United States51–200Biotech
Series C·$358.0M·Jan 2025
AI
AtaiBeckley Inc.IPO

Clinical-stage biopharmaceutical company developing effective, rapid-acting mental health treatme...

New York, United States51–200Biotech, Healthcare
Series D·$357.1M·Mar 2021
Inari Agriculture

AgTech company using AI-enabled predictive design and multiplex gene editing to create superior s...

Cambridge, United States201–500Biotech
Series G+·$357.0M·Jan 2024
BE Biopharma

Biotech company pioneering Engineered B Cell Medicines (BCMs) to treat genetic diseases like Hemo...

Cambridge, United States51–200Biotech, Healthcare
Series C·$356.0M·Jan 2025